R, S., M, H., EL, S., MJ, C., DP, L., MJ, H., . . . SS, K. (2022). Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Blood, 139(26), 3708. https://doi.org/10.1182/blood.2021012811
Chicago Style (17th ed.) CitationR, Sakemura, et al. "Targeting Cancer-associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-cell Therapy In multiple Myeloma." Blood 139, no. 26 (2022): 3708. https://doi.org/10.1182/blood.2021012811.
MLA (9th ed.) CitationR, Sakemura, et al. "Targeting Cancer-associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-cell Therapy In multiple Myeloma." Blood, vol. 139, no. 26, 2022, p. 3708, https://doi.org/10.1182/blood.2021012811.
Warning: These citations may not always be 100% accurate.
